Janney Capital Management LLC trimmed its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 10.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,656 shares of the biopharmaceutical company’s stock after selling 5,774 shares during the […]
Baxter Bros Inc. reduced its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 28.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 21,956 shares of the biopharmaceutical company’s stock after selling 8,919 shares during the period. Baxter Bros Inc.’s […]
Pettee Investors Inc. lowered its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 71,920 shares of the biopharmaceutical company’s stock after selling 476 shares during the quarter. Bristol-Myers Squibb accounts for […]
Apollon Wealth Management LLC raised its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 77,741 shares of the biopharmaceutical company’s stock after purchasing an additional 3,525 shares during the period. Apollon Wealth Management LLC’s holdings in Bristol-Myers […]
First City Capital Management Inc. decreased its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.3% in the fourth quarter, Holdings Channel.com reports. The firm owned 25,561 shares of the biopharmaceutical company’s stock after selling 614 shares during the period. First City Capital Management Inc.’s holdings in Bristol-Myers Squibb were worth $1,312,000 at the […]
Mid American Wealth Advisory Group Inc. raised its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.7% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 78,261 shares of the biopharmaceutical company’s stock after buying an additional 2,794 shares during the quarter. Bristol-Myers Squibb makes up about […]
Buckingham Capital Management Inc. decreased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 8.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,890 shares of the healthcare product maker’s stock after selling 7,110 shares during the quarter. Buckingham Capital Management […]
Foyston Gordon & Payne Inc lowered its holdings in American Express (NYSE:AXP) by 0.4% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 62,190 shares of the payment services company’s stock after selling 222 shares during the period. American Express makes up 2.9% of Foyston Gordon & […]
Loudon Investment Management LLC cut its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 24,693 shares of the company’s stock after selling 758 shares during the quarter. AbbVie makes up approximately 2.4% […]
Beacon Pointe Advisors LLC trimmed its holdings in shares of Verizon Communications Inc. (NYSE:VZ – Free Report) by 26.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 205,002 shares of the cell phone carrier’s stock after selling 72,020 […]
Vise Technologies Inc. trimmed its holdings in International Business Machines Co. (NYSE:IBM – Free Report) by 13.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 13,945 shares of the technology company’s stock after selling 2,147 shares during the period. Vise Technologies […]
Checchi Capital Advisers LLC trimmed its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 0.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,169 shares of the medical research company’s stock after selling 23 shares during the period. Checchi Capital Advisers LLC’s holdings […]